{"basic_info": {"ticker": "300119", "exchange": "XSHE", "bloomberg_ticker": "300119 CH Equity", "name": "TIANJIN RINGPU BIO-TECHNOL-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "瑞普生物", "period": "2020", "market_value": 7430544896, "total_income": 2000407106, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 2009130696, "business_income_over_total_income": 1.0043609073242314}, {"shariah_compliance": "unknown", "income": -8723592, "business_income_over_total_income": -0.004360908324027919}], "details": [{"business_activity_cn": "禽用生物制品", "business_activity_en": "Poultry Biological Products", "income": 961748718, "business_income_over_total_income": 0.48077649550201107, "shariah_compliance": "compliant"}, {"business_activity_cn": "原料药及制剂", "business_activity_en": "And drug formulation", "income": 885264342, "business_income_over_total_income": 0.4425420902299074, "shariah_compliance": "compliant"}, {"business_activity_cn": "畜用生物制品", "business_activity_en": "Veterinary biological products", "income": 162117636, "business_income_over_total_income": 0.08104232159231292, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 38410598, "business_income_over_total_income": 0.019201390499359684, "shariah_compliance": "unknown"}, {"business_activity_cn": "减：内部抵销数", "business_activity_en": "Less: Number of offset internal", "income": -47134190, "business_income_over_total_income": -0.023562298823387604, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.047908490260740545, "shariah_compliance": "compliant", "amount_over_market_value": 0.047908490260740545}]}